Literature DB >> 23175501

Five years (2004-2009) of a restrictive law-regulating ART in Italy significantly reduced delivery rate: analysis of 10,706 cycles.

P E Levi Setti1, E Albani, M Matteo, E Morenghi, E Zannoni, A M Baggiani, V Arfuso, P Patrizio.   

Abstract

STUDY QUESTION: Was the delivery rate of ART cycles negatively affected by the enactment of the Law 40/2004 by the Italian Parliament which imposed a long list of restrictions for ART procedures? SUMMARY ANSWER: This large and extensive comparative analysis of ART outcomes prior to and after the introduction of the Law 40 revealed a significant reduction in pregnancy and delivery rates per cycle, independent of age or other clinical variables, once the law went into effect. WHAT IS KNOWN ALREADY: Several studies have been published on the effect of Law 40/2004 on ART outcomes, some authors demonstrating a negative impact of the Law in relation to specific etiologies of infertility, other authors showing opposite conclusions. STUDY DESIGN, SIZE, DURATION: Retrospective clinical study of 3808 patients treated prior to the enactment of the Law, September 1996-March 2004 (Group I) and 6898 treated during the Law, March 2004-May 2009 (Group II). PARTICIPANTS/MATERIALS, SETTING,
METHODS: A total of 10 706 ART cycles were analysed, 3808 performed before and 6898 after the application of the Law. An intention-to-treat statistical analysis was performed to detect pregnancy and delivery rates (pregnancies ≥ 24 weeks) per started cycle. A P value of <0.05 was considered statistically significant. We analysed different outcomes: differences in fertilization, pregnancy and delivery rate, multiple pregnancies and miscarriage rates between the two time periods. MAIN RESULTS AND THE ROLE OF CHANCE: The delivery rate for started cycle was 20% before and 16.0% after the introduction of the Law representing a 25% reduction (P < 0.001). The multivariate analysis, corrected by female age of >38 years, duration of infertility, basal FSH level and number of retrieved oocytes, showed a 16% lower delivery rate (odds ratio: 0.84; confidence interval: 0.75-0.94). This statistical approach removed the risk that the observed effects were due to chance and confirmed unequivocally that the Law was an independent factor responsible for the reduced likelihood of a successful outcome. LIMITATIONS, REASONS FOR CAUTION: This is a retrospective study. A prospective randomized study, with patients treated in the same time period and randomized to restrictions or not, would have minimized potential limitations due to differences in years of treatments. WIDER IMPLICATIONS OF THE
FINDINGS: Our findings based on the analysis of such a large number of cycles proved clearly and unequivocally that imposing restrictions on the practice of ART penalized patients. These data represent a relevant clinical contribution for countries still debating the enactment of restrictive limitations of ART.

Entities:  

Mesh:

Year:  2012        PMID: 23175501     DOI: 10.1093/humrep/des404

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  ART results with frozen oocytes: data from the Italian ART registry (2005-2013).

Authors:  Paolo Emanuele P E Levi-Setti; Andrea Borini; Pasquale Patrizio; Simone Bolli; Vincenzo Vigiliano; Roberto De Luca; Giulia Scaravelli
Journal:  J Assist Reprod Genet       Date:  2015-12-16       Impact factor: 3.412

2.  Testicular sperm extraction and intracytoplasmic sperm injection outcome in cancer survivors with no available cryopreserved sperm.

Authors:  Paolo Emanuele Levi-Setti; Luciano Negri; Annamaria Baggiani; Emanuela Morenghi; Elena Albani; Carola Maria Conca Dioguardi; Cristina Specchia; Pasquale Patrizio
Journal:  J Assist Reprod Genet       Date:  2020-01-24       Impact factor: 3.412

3.  Delayed childbearing and female ageing impair assisted reproductive technology outcome in survivors of male haematological cancers.

Authors:  Paolo Emanuele Levi-Setti; Luciano Negri; Annamaria Baggiani; Emanuela Morenghi; Elena Albani; Valentina Parini; Luca Cafaro; Carola Maria Conca Dioguardi; Amalia Cesana; Antonella Smeraldi; Armando Santoro
Journal:  J Assist Reprod Genet       Date:  2018-08-10       Impact factor: 3.412

4.  No advantage of fresh blastocyst versus cleavage stage embryo transfer in women under the age of 39: a randomized controlled study.

Authors:  Paolo Emanuele Levi-Setti; Federico Cirillo; Antonella Smeraldi; Emanuela Morenghi; Giulia E G Mulazzani; Elena Albani
Journal:  J Assist Reprod Genet       Date:  2017-11-22       Impact factor: 3.412

5.  Obstetric outcome and incidence of congenital anomalies in 2351 IVF/ICSI babies.

Authors:  Paolo Emanuele Levi Setti; Melita Moioli; Antonella Smeraldi; Elisa Cesaratto; Francesca Menduni; Stefania Livio; Emanuela Morenghi; Pasquale Patrizio
Journal:  J Assist Reprod Genet       Date:  2016-04-26       Impact factor: 3.412

6.  The human factor: does the operator performing the embryo transfer significantly impact the cycle outcome?

Authors:  F Cirillo; P Patrizio; M Baccini; E Morenghi; C Ronchetti; L Cafaro; E Zannoni; A Baggiani; P E Levi-Setti
Journal:  Hum Reprod       Date:  2020-02-29       Impact factor: 6.918

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.